Science Explorer Back to mapMap

Most cited papers from California Dental Association Foundation

California Dental Association Foundation

What are the most cited papers from California Dental Association Foundation?

The most cited paper from California Dental Association Foundation is "Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs" (Jason Grebely, Sarah Larney, Amy Peacock et al., 2018), with 262 citations. Next come "Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage" (129) and "Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis" (35).

Showing 17 of 17 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs Jason Grebely, Sarah Larney, Amy Peacock et al. · Addiction Open access 23 Jul 2018 262
2 Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage Mark E. Brecher, Paul V. Holland, Alvaro A. Pineda et al. · Transfusion Nov 2000 129
3 Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis Young‐Suk Lim, Sang Hoon Ahn, Jae‐Jun Shim et al. · Alimentary Pharmacology & Therapeutics Open access 25 May 2022 35
4 Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany Tammo Lambert Tergast, Sarah Blach, Frank Tacke et al. · Journal of Viral Hepatitis Open access 31 Mar 2022 26
5 HCV disease burden and population segments in Switzerland Florian K. Bihl, Philip Bruggmann, Erika Castro Batänjer et al. · Liver International Open access 28 Nov 2021 22
6 The current and future burden of hepatitis B in Switzerland: a modelling study Francesco Negro, Beat Müllhaupt, David Semela et al. · Swiss Medical Weekly Open access 5 Jun 2023 7
7 Financial risk protection from vaccines in 52 Gavi-eligible low- and middle-income countries: A modeling study Boshen Jiao, Ryoko Sato, Joshua Mak et al. · PLoS Medicine Open access 4 Nov 2025 5
8 From targets to real world impact: a review of models of care for chronic HBV and HCV in Europe Camila A. Picchio, Aina Nicolàs, Erika Duffell et al. · The Lancet Regional Health - Europe Open access 25 May 2026 4
9 Strategies to eliminate hepatitis C in Croatia, a modelling study Adriana Vince, Ellen Dugan, Tatjana Nemeth Blažić et al. · Liječnički vjesnik Open access 4 Nov 2020 4
10 Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial Sarah Blach, Andrea Bregenzer, Philip Bruggmann et al. · Journal of Viral Hepatitis 8 Aug 2023 3
11 Pathogens, Testing and Vaccines: California Dentists’ Role in the Public Health Response to COVID-19 Richard Graham, Richard E. Barnes, Tooka Zokaie et al. · Journal of the California Dental Association Open access 31 Jul 2023 2
12 Can remittances increase charitable giving among immigrant families? Janice Gow Pettey · New Directions for Philanthropic Fundraising Sep 2002 2
13 Medical–Dental Integration: Exploring Our Role in Collaborative Health Care Richard W. Graham · Journal of the California Dental Association Open access 31 Aug 2023 1
14 Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic Olivier Schorr, Sarah Blach, Christine Thurnheer et al. · PLoS ONE Open access 12 Aug 2022 1
15 Threats and Harassment of Election Officials Resulting from the 2020 Election Alexander Alexeevich Kim, Grace Gordon · Elections, Voting, Technology. Book chapter 2024 0
16 Response to “Reply to ‘Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial’” Homie A. Razavi, Sarah Blach, Andrea Bregenzer et al. · Journal of Viral Hepatitis 8 Dec 2023 0
17 Stat testing in the new CLIA era. Kathleen J. Sazama · PubMed Dec 1991 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.